Christopher Ogden - 18 Mar 2025 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Christopher Ogden
Issuer symbol
CTMX
Transactions as of
18 Mar 2025
Net transactions value
-$5,122
Form type
4
Filing time
20 Mar 2025, 16:33:49 UTC
Previous filing
06 Feb 2025
Next filing
17 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale $5,122 -8,551 -4.1% $0.5990 201,026 18 Mar 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units ("RSUs").
F2 Includes 155,821 RSUs.